Irf7 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Official Symbol: IRF7
Official Full Name: Interferon Regulatory Factor 7
Location: Chromosome 11p15.5
Gene ID: 3665
Interferon Regulatory Factor 7 (IRF7) is a master regulator of type I interferon (IFN-α/β) gene expression and plays a pivotal role in the innate immune response. It is particularly important for the amplification of interferon responses and is expressed predominantly in lymphoid tissues and plasmacytoid dendritic cells.
The IRF7 gene spans approximately 7.5 kb and consists of 9 exons. It encodes multiple isoforms through alternative splicing, with the major isoform being 503 amino acids (55 kDa).
IRF7 contains:
IRF7 is the master regulator of type I interferon-dependent immune responses. Unlike IRF3, IRF7 is primarily responsible for the amplification of interferon responses and is essential for the induction of IFN-α genes.
IRF7 expression is highest in:
| Disease | Mechanism | Evidence |
|---|---|---|
| Alzheimer's Disease | Chronic inflammation, IFN signature | Transcriptomic studies |
| Parkinson's Disease | Microglial activation | Animal models |
| ALS | Neuroinflammation | Expression studies |
| Viral Encephalitis | Antiviral response | Clinical studies |
IRF7 represents a therapeutic target:
The study of Irf7 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.